Prostate cancer (PCa) is the most commonly diagnosed cancer in men with an estimated 23,600 new cases in 2013 and it is the third leading cause of cancer-related death in Canadian men.
The Canadian Prostate Cancer Biomarker Network (CPCBN) is a research program directed by a group of clinicians and scientists with the ultimate goal of improving the clinical management of men with prostate cancer.
Access the CPCBN repository
To access the repository, researchers should complete an application form, which will be assessed by the study committee. All images and results must be returned to the CPCBN on completion of the study.
To submit your completed application, or for more information, please contact Véronique Ouellet.
The information on these webpages and more details about the CPCBN project can be found in the CPCBN pamphlet.